Joel Litman SynBio Stock Revealed: Is It Legit?

Joel Litman and the team at Altimetry are out with a new video presentation for Hidden Alpha Research, featuring Joel Litman’s favorite SynBio Investment Right Now. Continue reading to get the details…

Watch Joel Litman’s SynBio presentation here

Have you watched Joel Litman’s SynBio presentation by Altimetry Research? If you did not have time to watch the video, here are the most important details to find out is it worth your time.

First, we’ll introduce you to Joel Litman…

Who is Joel Litman?

He is forensic accountant and for many years he has been working with most powerful agencies like FBI and the U.S. Marine Corp War College.

His global Business has 150 employees working from three continents.

He and his team run weekly forensic data reports on more than 25,000 publicly traded companies. It is not a typo. Tracking 25,000 companies each week is means a lot of work. Litman is sure than no one on or off Wall Street comes close to the scale of his work.

Litman and his team started this campaign because they believe they uncovered where is the Next Big Wave of Money headed ….


— RECOMMENDED —

Joel Litman Winning Sector Portfolio PicksThe Market Hasn’t Done This in 15 Years

Wealth has evaporated. Companies are announcing salary freezes and unpaid furloughs. The price of everything keeps climbing while the values of our most precious assets, like our homes and investment accounts, are depreciating. There’s a strange reason why, but Wall Street won’t tell you about it.

Click here to get the full story.


Joel Litman’s SynBio is where the Next Big Wave of Money is headed

They claim that their new initiative will give regular folks the same advantages as their billion-dollar clients.

I’m sure you’ve noticed in the last few months how digital technology companies have crashed from their highs.

Facebook’s sudden drop was covered by all mainstream media.

Companies like Docusign, Twitter, Shopify, and many more have fallen 40% plus.

Litman and his team believe they know where the smart money is heading next. It is a subsector of the markets very few people are paying attention. The chance is you’ve never heard of it.

Litman is talking about a group of companies that will form the New Technological Era.

It was the subject of Apple founder Steve Jobs’ “Final Prophecy” back in 2011, just before he passed away.


— RECOMMENDED —

A New Way To See Which Stocks Could Double Your Money

Marc Chaikin Power Gauge Investor Review

We want to give you FREE access to the Power Gauge system ($5,000 value).

Claim FREE access to The Power Gauge Here


How Steve Jobs’ “Final Prophecy” came to life?

Steve Jobs is the person who predicted the laptop, cloud computing and many more. He was the one who predicted how the combination of internet, software and voice recognition will create voice activated assistants like Amazon’s Alexa and Apple’s Siri.

Do you think that Steve’s Jobs “Final Prophecy” issued in 2011 will be his most important prediction?

Litman believes that in 2020 we witnessed one of the most important technological breakthroughs of our time.

It is the most important technology of the next decade, called “SynBio”.

It started when Barney Graham and his team from Moderna were able to pinpoint COVID-19 spike protein by using variety of software.

What is incredible is that Graham and his team were able to design a new vaccine in just few hours digitally on their laptops, after gaining access to the genomic sequence. They never had the virus on site.

We are now about to enter the biggest new health wave. And new vaccines are only tiny part of it. No matter if you personally believe in these new vaccines or not.

Eleven years ago, in his biography Steve Jobs predicted what would change the world.

Steve Jobs Final Prophecy Joel Litman Synbio

Source: altimetry.com

What is actually SynBio?

SynBio is the combination of computer science with genomic analysis and gene editing. It is being used to create new materials, new medicines, new food, and many more new products.

SynBio is entirely new field. It was born because the price of sequencing DNA now is 1/10 of what it cost 20 years ago. Computers now are many times faster than they were few years ago. SynBio will allow us to create, manufacture, and improve many things, starting at cellular level.

It will transform every industry over the next decade, making early investors really, really rich.

Joel Litman gives an example with cotton, which is used in half of all textiles. There hasn’t been a big innovation in the cotton industry for more than 200 years.

Typically, cotton takes 180 days to grow, and 10 tons of water for each pair of jeans.

Thanks to SynBio, a Massachusetts company is growing cotton 10 times faster in a lab. They go directly from the cell to the fiber and use 80% less water and land.

The whole process takes only 18 days and does not require insecticides or pesticides.

Use this link to watch the presentation for more examples how this will be a disruption to entire industries.

The same thing that is happening to cotton industry is now taking place with leather, plastic, rubber and many more.

Bolt Threads, a company in the leather business is starting to produce a million square feet of lab-grown leather per year. They already established partnerships with Adidas and Lululemon.

The market for leather from cows is expected to collapse by 90% in the next few years.

Here is one more extraordinary example: Currently every big software company is working to perfect the path to use biological DNA for data storage.

SynBio scientists and engineers found a way to store our photos, videos, movies, music, etc. instead of hard drives, on computers in synthetic DNA.

Why? Because DNA is stable and dense. It is estimated that one kilogram of DNA could store all the data of the world.

Another plus is that DNA lasts for thousands of years. Scientists have been able to find readable DNA extracted from a horse that died 700,000 years ago.

The main thing is that SynBio is going to transform the world as we know it. The change will be in so many ways that we can’t imagine right now.


— RECOMMENDED —

Severe Stock Warning: A New Financial Crisis Is Underway

It doesn’t matter if you have money in the markets right now, or you’re waiting on the sidelines. The short period we’re about to enter could have the power to make – or destroy – fortunes. And what you do in the coming days could determine your wealth for the next decade. Here’s what’s happening and how to prepare.

Click here for details


Joel Litman SynBio Opportunity – what does this mean for investors?

In 2021, SynBio funding increased more than 100% compared to the previous year. The venture money that went into SynBio companies last year only was more than the previous 10 years combined together.

It is good place to mention here that the people that became billionaires in the digital computing era (the previous big wave of money), are now moving money into SynBio companies.

The good news is that you can be among early investors and get in at really low prices. Now, before the rest of the world are focused someplace else.

Of course, you can wait to see what will happen. You will still have the chance to make good money as this becomes the dominant tech trend of the next decade.

You got the point.

SynBio approach will make resources cleaner and cheaper.

The next big stock market winners will be among businesses developing green products like green agriculture, green cement, etc.

How to invest in Joel Litman SynBio Stock?

Here are Joel Litman’s steps:

Step #1: Buy ILMN, stock symbol I-L-M-N.

The entire SynBio process starts with gene sequencing. There is one company that by far offers the most powerful DNA sequencing. It controls around 90% of this market. In 2021 company’s revenue grew 25% in the fourth quarter. The firm added 50% more customers in 2020.

Today, Illumina has 17,000 DNA sequencing machines, used by nearly all big drug companies like Merck, Bayer, and Bristol Myers.

Illumina owns a blood test that helps identify 50 types of cancer before the symptoms appear.

Litman’s recommendation is to buy Illumina today (up to $510 per share) and keep it for a long run. Based on his analysis, Illumina should be worth around 20% more in a year, 40% more in two years, and about 130% more in five years.

Illumina is already a big company. That’s why Litman believes there are other ways to potentially make a lot more money in the SynBio space.


— RECOMMENDED —

Greg Diamond Get Out of Cash EventThe Man Who Nailed the 2022 Crash Issues a NEW Prediction

Get out of cash and back into the market. But it’s important you do this in a very particular way – which has nothing to do with buying stocks, bonds, cryptos, or any conventional investment. Ignore us, if you’d like… But this prediction comes from the man who called the 2022 crash a day before it began.

Click here to learn more.


Step #2: The next wave of big profits.

Buy the next wave of big SynBio winners.

The mRNA vaccines, produced by Pfizer and Moderna are SynBio drugs that marked the starting point of the future activities in this space.

Currently the best labs in the world use the same mRNA technology to create the new types of treatments. There are about 520 mRNA-based clinical trials, and the best of these prospects should produce huge stock market winners.

Scientists have been working on this technology for years, but now it has been proven in the real world.

The next mRNA vaccine is likely to be for the flu and HIV.

Joel Litman wrote a brand-new report called “Profiting From the Next Big SynBio Wave”. It shows exactly which two stocks to look at right now. What to buy, and at what price.
His recommendation is to take position, then sell half after you’ve pocketed 100% gains. This will allow you to keep your initial investment. This approach is a great way to limit your risk and still have huge potential.

There are few other investments that he recommends.

Step # 3: Buy the Platforms

One of the best ways to make profit from a new technology is to “own the platforms”. Platforms are companies that create systems or marketplaces, allowing other businesses to sell their products. Examples are Google, eBay, Amazon, etc.

Litman’s recommendation is to invest in two SynBio platform companies that he believes will dominate in the near future. Potentially these companies will make a lot of money for their early investors.

Everything you need to know about these two companies is included in a special report called “Buy the Platforms – Your Best Shot at a 1,000% Winner”.

Here is some information how you can get a hold of these reports:

What is Hidden Alpha Research?

Hidden Alpha is a monthly stock research service. According to Joel Litman, their work on small stocks has more than doubled the performance of the S&P stock market averages over the past 18 months. In the last two years, they’ve had 16 winners with 100% plus.

They charge their corporate clients as much as $1.2 million per year for access to their data.

Two years ago, they created a special version of their research for regular investors.


— RECOMMENDED —

Huge Recession Loophole (See These Charts)

Amid today’s market turmoil, THIS is one of the biggest and most bullish opportunities today: a red-hot sector with almost unlimited pricing power and a history of outperforming in recessions. It’s also the sector where our good friend Dr. David Eifrig spent half his professional life – meaning he’s extremely qualified to spot world-class opportunities today.

Take a look at the evidence here.


What is included with Hidden Alpha subscription (Joel Litman SynBio offer)?

Here is the list of what you will receive when you start a no-risk, trial subscription to Hidden Alpha:

  • For the next 12 months you will have access to their best new ideas and top recommendations. You will always know exactly what to buy and what to sell. You will also know the exact steps if you decide to follow their recommendations.
  • Access to Altimetry Daily Authority. This is their daily email market update delivered every day when the markets are open. These daily reports are much more valuable than anything you will hear or read in the mainstream press each day.
  • Full immediate access to all archived research reports and recommendations, including “The Future Of Medicine” and “3 Companies That will Lead the EV (electric vehicle) Revolution”
  • Special Report #1: My Favorite SynBio Investment Right Now. In this report are listed not only their recommendations, but also full list of companies you want to avoid in this space.
  • Special Report #2: Profiting from the Next Big SynBio Wave. Here you will find the two companies among 520 mRNA clinical drug trials that are set for biggest returns.
  • Special Report #3: Buy the Platforms – Your Best Shot at a 1,000% Winner. Here you will find another two great firms. One of these companies has the best chance to make 100-times your money in the long run.

Joel Litman Hidden Alpha SynBio Reports

Source: altimetry.com

  • Special Report #4: The Perfect Portfolio. In this detail analysis you will find their favorite investments right now. You will find the way to build perfectly allocated portfolio that includes an electric vehicle stock, a gambling firm, e-commerce business, software firm, great precious metal mining investment, and few more.

How much costs Hidden Alpha?

Normally their basic subscription for individuals is $200 per year. If you use this link for short period of time you will be able to make full year subscription for more than 75% OFF.

Here are the subscription levels:

  • Basic for $49 (Regular price $199)
  • Premium $79 (regular price $398). This is the most popular choice. It includes one additional report called America’s Next Big Monopoly written by Wall Street legend Whitney Tilson. This subscription includes also 1-year free, no obligation subscription to Whitney Tilson’s Empire Stock Investor research service ($199 value).
  • Deluxe $129 (regular price $599). It includes everything in Premium subscription plus another research report called “Altimetry’s Top 5 Microcaps for 2022.

Keep in mind that all investments carry risk. The fact that their Top 10 picks have outperformed the S&P 500 index by almost 100% does not guarantee their future success.


— RECOMMENDED —

Economic Reckoning Coming to America

For most people, what’s coming will prove challenging. But while the majority of Americans will be caught off guard, one senior analyst says following a few clear steps today could position you to make triple-digit gains over the next six months.

See his brand-new prediction and what it could mean for your money right here.


Bottom Line: Should You Join Hidden Alpha?

We will recommend you spend some time to read what other subscribers think about their service.

Of course, the best way to decide if something is right for you is to try it yourself.

Their 30 days refund policy comes right on time. It is the same for all subscription levels. During these 30 days you can cancel online or over the phone for full refund.

The frenzy in SynBio has already begun in the private sector. Soon it will reach the public stock market. Who wants to be there first?

We are very excited about this development and believe that this incredible trend will soon change the world. The truth is that many of these investments are very cheap today. But they will not stay like that for long.

Ready To Try Hidden Alpha? Click Here – Best Offer + Bonus


You may also like these posts...

Tom Gentile's Four-Day Profit Cycle Technique

Tom Gentile’s Four-Day Profit Cycle Technique: Weekly Cash Clock Review

Tom Gentile's Four-Day Profit Cycle is the latest marketing campaign promoting Tom Gentile's Weekly Cash Clock research service. Tom Gentile claims that with this Four-Day Profit Cycle incredible technique, you can take a Small Account and 10X Your Money in Just Four Months. Keep reading to learn the truth...
High Conviction Investor Review

High Conviction Investor Review – Is Thompson Clark’s Service Legit?

Looking for more information about Thompson Clark's High Conviction Investor research? I've put an honest High Conviction Investor Review, containing everything we know so far for Thompson Clark’s brand new service.